Sort by
Refine Your Search
-
Listed
-
Employer
- ;
- KINGS COLLEGE LONDON
- University of Oxford
- Durham University
- Heriot Watt University
- King's College London
- University of Glasgow
- University of London
- AALTO UNIVERSITY
- Manchester Metropolitan University
- UNIVERSITY OF VIENNA
- University of Liverpool
- ; CRUK Scotland Institute
- Aston University
- DURHAM UNIVERSITY
- Imperial College London
- Oxford Brookes University
- 7 more »
- « less
-
Field
-
against cancer. Within the School, the Comprehensive Cancer Centre (CCC) integrates molecular discovery, drug-development pipelines and patient-facing trials, with strengths in personalised medicine, immuno
-
in close collaboration with researchers at the James Black Centre in the Denmark Hill Campus, where the experimental work will take place. There is a unique infrastructure to support cutting-edge
-
Motion Laboratory, a multi-disciplinary research group investigating different aspects of animal structure and movement. The post holder will join Professor Richard Bomphrey’s research group to work on a
-
value of benefits provided by Heriot-Watt University Detailed Description This project is part of the new UK Hub in Quantum Sensing Imaging and Timing (QuSIT), that stands as an international centre
-
in close collaboration with researchers at the James Black Centre in the Denmark Hill Campus, where the experimental work will take place. There is a unique infrastructure to support cutting-edge
-
: Analyze and integrate clinical and multi-omic datasets from rare disease cohorts. Develop and apply network medicine tools, particularly multiplex network-based models, to address specific challenges in
-
subcellular dysfunction in synapses of neurons from ALS/FTD patients using multi-omics. They will work under Dr Ruxandra Dafinca’s supervision ( https://www.ndcn.ox.ac.uk/team/ruxandra-dafinca ) in a
-
populations using patient samples and employing a combination of multi-modal techniques (scRNA-seq, scATAC-seq, ResolveOME) to develop novel assays for disease monitoring. The post is based at the Barts Cancer
-
populations using patient samples and employing a combination of multi-modal techniques (scRNA-seq, scATAC-seq, ResolveOME) to develop novel assays for disease monitoring. The post is based at the Barts Cancer
-
of the research group led by project investigator, Dr Krystyna Cwiklinski, and have the opportunity to work with colleagues at the Centre for Genomic Research (led by project partners Professor Al